GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Change In Other Working Capital

Y-Biologics (XKRX:338840) Change In Other Working Capital : ₩-110 Mil (TTM As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics Change In Other Working Capital?

Y-Biologics's Change In Other Working Capital for the quarter that ended in Mar. 2025 was ₩165 Mil. It means Y-Biologics's Other Working Capital increased by ₩165 Mil from Dec. 2024 to Mar. 2025 .

Y-Biologics's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was ₩-129 Mil. It means Y-Biologics's Other Working Capital declined by ₩129 Mil from Dec. 2023 to Dec. 2024 .

Y-Biologics Change In Other Working Capital Historical Data

The historical data trend for Y-Biologics's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics Change In Other Working Capital Chart

Y-Biologics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Other Working Capital
Get a 7-Day Free Trial -823.00 2,663.90 704.94 -2,261.96 -129.35

Y-Biologics Quarterly Data
Dec17 Dec18 Dec19 Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 145.79 243.97 218.25 -737.37 165.30

Y-Biologics Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-110 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Y-Biologics Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Y-Biologics's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Y-Biologics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Change In Other Working Capital
Comparable Companies
XKRX:214260 XKRX:251120 XKRX:048530 XKRX:311690 XKRX:278650 XKRX:456070 XKRX:084990 XKRX:235980 XKRX:299660 XKRX:376270 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
B715 Daedeok Biz Center, 17 Techno 4-ro, Yuseong-gu, Daejeon, KOR, 34013
Website
https://www.ybiologics.com
Y-Biologics Inc is a company that has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of the development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics Headlines

No Headlines